Outcomes after Transplant in Relapsed/Refractory KMT2Ar (mllr) and Mnpm1 (npm1c) Leukemia Patients Achieving Remissions after Menin Inhibition: SNDX-5613 (revumenib) Ph1 Experience
Blood(2022)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Blood(2022)